TAMMY UNDERWOOD: Open Payments
NPI 1902587405 · CLAYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 30 payments from 14 companies in 2025. Trend: 2023 $100 · 2024 $566 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| PFIZER INC. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| ABBVIE INC. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| ACADIA Pharmaceuticals Inc | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: ELIQUIS, AIRSUPRA, VOQUEZNA, TRELEGY ELLIPTA, GARDASIL 9, DAYBUE, NEXLETOL, Auvelity.
Industry payments across PA — which companies pay providers there.
